Company · CIK 1937993
Cadrenal Therapeutics, Inc.
| CIK | 1937993 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | FL |
| Listed | CVKD (Nasdaq) |
| First annual or quarterly report | 2023-03-30 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-297432 | 2026-07-13 | 2026-07-20 | 2 | |
| 333-295200 | 2026-04-21 | 2026-04-29 | 2 | |
| 333-283226 | 2024-11-14 | 2026-04-01 | 3 | |
| 333-292444 | 2025-12-29 | 2025-12-31 | 2 | |
| 333-277835 | 2024-03-12 | 2025-12-23 | 8 | |
| 333-273384 | 2023-07-24 | 2024-11-04 | 4 | |
| 333-267562 | 2022-09-22 | 2023-01-23 | 10 |
Filings
32| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-20 | EFFECTDeclared effective | 333-297432 | 9999999995-26-002367 |
| 2026-07-13 | S-3Shelf registered | 333-297432 | 0001213900-26-077647 |
| 2026-04-29 | EFFECTDeclared effective | 333-295200 | 9999999995-26-001386 |
| 2026-04-21 | S-3Shelf registered | 333-295200 | 0001213900-26-045776 |
| 2026-04-01 | 424B5Shelf takedown | 333-283226 | 0001213900-26-038010 |
| 2025-12-31 | EFFECTDeclared effective | 333-292444 | 9999999995-26-000024 |
| 2025-12-29 | S-1Registration filed | 333-292444 | 0001213900-25-125526 |
| 2025-12-23 | 424B5Shelf takedown | 333-277835 | 0001213900-25-125427 |
| 2025-12-16 | 424B5Shelf takedown | 333-277835 | 0001213900-25-121930 |
| 2025-12-16 | 424B5Shelf takedown | 333-277835 | 0001213900-25-121928 |
| 2025-11-18 | 424B5Shelf takedown | 333-277835 | 0001213900-25-112118 |
| 2025-04-17 | 424B5Shelf takedown | 333-277835 | 0001213900-25-032730 |
| 2024-12-20 | 424B5Shelf takedown | 333-277835 | 0001213900-24-111291 |
| 2024-11-22 | EFFECTDeclared effective | 333-283226 | 9999999995-24-003563 |
| 2024-11-14 | S-3Shelf registered | 333-283226 | 0001213900-24-098411 |
| 2024-11-04 | 424B5Shelf takedown | 333-273384 | 0001213900-24-093778 |
| 2024-04-02 | EFFECTDeclared effective | 333-273384 | 9999999995-24-000826 |
| 2024-03-20 | EFFECTDeclared effective | 333-277835 | 9999999995-24-000694 |
| 2024-03-12 | S-3Shelf registered | 333-277835 | 0001213900-24-021580 |
| 2023-07-28 | EFFECTDeclared effective | 333-273384 | 9999999995-23-002217 |
| 2023-07-24 | S-1Registration filed | 333-273384 | 0001213900-23-059047 |
| 2023-01-23 | 424B4Final prospectus | 333-267562 | 0001213900-23-004435 |
| 2023-01-23 | 424B4Final prospectus | 333-267562 | 0001213900-23-004433 |
| 2023-01-19 | EFFECTDeclared effective | 333-267562 | 9999999995-23-000131 |
| 2023-01-17 | S-1/AAmendment | 333-267562 | 0001213900-23-002924 |
| 2022-12-28 | S-1/AAmendment | 333-267562 | 0001213900-22-083009 |
| 2022-12-08 | S-1/AAmendment | 333-267562 | 0001213900-22-078525 |
| 2022-12-06 | S-1/AAmendment | 333-267562 | 0001213900-22-077850 |
| 2022-10-17 | S-1/AAmendment | 333-267562 | 0001213900-22-064170 |
| 2022-10-11 | S-1/AAmendment | 333-267562 | 0001213900-22-062909 |
| 2022-09-22 | S-1Registration filed | 333-267562 | 0001213900-22-058071 |
| 2022-07-15 | DRSDraft made public | 377-06275 | 0001213900-22-039474 |